Clinical trial
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
NCT00179881 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Completed
Key facts
| NCT number | NCT00179881 |
|---|---|
| Title | Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma |
| Official title | Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Stem Neoplasms, Primary, Neoplasms, Brain Stem |
| Intervention type | Drug, Procedure |
| Interventions | Carboplatin, Thalomid, External Beam Radiation Therapy |
| Enrollment | 47 |
| Start date | Dec 1, 1999 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: